関連する実験動画
Updated: Jul 16, 2026

11:56
Nanomechanics of Drug-target Interactions and Antibacterial Resistance Detection
Published on: October 25, 2013
D-Ala-D-lac結合は,バンコマイシンジマーがバンコマイシン耐性腸内球菌に対して高い活性を持つために必要とされません
Rishi K Jain1, Joaquim Trias, Jonathan A Ellman
1Department of Chemistry, University of California, Berkeley, California 94720, USA.
Journal of the American Chemical Society
|July 17, 2003
まとめ
共同的バンコマイシン二重体は,バンコマイシン耐性腸球菌 (VRE) に対して高い活性を示しています. その有効性は,Lys-d-Ala-d-Lacペプチドに結合するメカニズムを超えて,損傷した場合でも発生します.
科学分野:
- 薬用化学 薬用化学について
- 微生物学 微生物学とは
- ドラッグ・ディスカバリー・ドリッグ・ディスカバリー・ドリッグ・ディスカバリー・ドリッグ・ディスカバリー
背景:
- 腸内細菌 (VRE) のヴァンコミシン耐性症は,重要な臨床的課題である.
- ヴァンコマイシンの共性二酸化は,新しい抗VRE剤の開発の鍵となる戦略です.
研究 の 目的:
- バンコマイシン二重体の抗VRE活性におけるペプチド結合の役割を調査する.
- 作用のメカニズムがLys-d-Ala-d-Lac.Lac.との結合に依存しているかどうかを判断する.
主な方法:
- 損傷したバンコマイシン (デスレウシル) から共振ダイマーを調製する.
- これらの二次元の抗VRE活動の測定.
- モデルペプチド (Lys-d-Ala-d-Lac) との結合親和性の評価.
主要な成果:
- 損傷したバンコマイシンジメは,無傷のジメと比較して,モデルペプチドへの結合親和性が低下した.
- 結合が減少したにもかかわらず,損傷したジメルは有意な抗VRE活性を維持しました.
- これは,結合独立のメカニズムがそれらの有効性に貢献することを示唆しています.
結論:
- コヴァラントバンコマイシン二重体の高抗VRE活性性は,Lys-d-Ala-d-Lac標的への結合にのみ依存するものではありません.
- 代替メカニズムは,これらのバンコマイシンアナログのVREに対する有効性に大きく貢献します.
関連する概念動画
Combined Effects of Drugs: Synergism
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents
Acute diarrhea, a common gastrointestinal disturbance, is characterized by the rapid evacuation of fluid stools, leading to an excessive weight in fluid. This condition typically arises from disorders affecting intestinal water and electrolyte transport. It can be triggered by an increased osmotic load within the intestine, excessive secretion of electrolytes and water, mucosal exudation of protein and fluid, or altered intestinal motility. The primary risks of acute diarrhea are dehydration...
Drugs for Treatment of Diarrhea-Predominant IBS
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Drugs for Treatment of Ulcerative Colitis in IBD
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide generation.
Inhibitors of Gram-positive Cell Wall Synthesis
Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
Clinical Significance of Antibiotic Resistance
Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...

